Table 2—

HbA1c, insulin dose, and insulin sensitivity by level of LTPA

SedentaryModerately activeActiveP
All patients (n = 1,030)
    HbA1c (%)
        Women8.8 ± 1.4*8.3 ± 1.48.3 ± 1.40.004
        Men8.4 ± 1.38.2 ± 1.48.2 ± 1.30.844
    Insulin (IU · kg−1 · 24 h−1)
        Women0.71 ± 0.220.71 ± 0.230.66 ± 0.220.036
        Men0.74 ± 0.210.71 ± 0.200.68 ± 0.230.003
    eGDR (mg · kg−1 · min−1)
        Women6.8 (4.6–8.7)7.4 (5.3–9.2)7.3 (5.5–9.2)0.038
        Men4.7 (3.5–7.4)5.4 (3.9–8.1)5.5 (4.0–8.0)0.052
Without complications (n = 624)
    HbA1c (%)
        Women8.7 ± 1.4*8.2 ± 1.38.2 ± 1.30.042
        Men8.3 ± 1.38.1 ± 1.48.1 ± 1.20.659
    Insulin (IU · kg−1 · 24 h−1)
        Women0.72 ± 0.200.72 ± 0.240.67 ± 0.200.229
        Men0.76 ± 0.210.74 ± 0.230.69 ± 0.230.013
    eGDR (mg · kg−1 · min−1)
        Women8.0 (5.8–9.0)8.3 (6.2–9.4)8.5 (6.5–9.7)0.191
        Men6.0 (4.1–8.2)7.0 (4.6–8.4)7.6 (5.1–8.5)0.090
  • Data are means ± SD or median (interquartile range).

  • *

    * P < 0.017 vs. moderately active;

  • P < 0.017 vs. active;

  • excluding patients with elevated UAER, myocardial infarction, coronary artery bypass, limb amputation, peripheral artery bypass, or stroke.